Readers may have missed a recent note on the 8 March 2011 decision the Barcelona Court of Appeal to lift the preliminary
ex parte injunctions sought by Lundbeck against various companies selling generic escitalopram medicaments for which they had obtained marketing approval. This decision upheld the decision of Barcelona Commercial Court No 4 in April of last year. At stake were Lundbeck's patent EP347.066 - ES2.986.891 and SPC 200200019, which claimed a certain manufacturing process for the active ingredient escitalopram.
The main trial in the first instance main proceedings is due to take place in July 2011.
Details of this dispute so far can be found in the source referred to below.
Source: "Appeal court lifts preliminary injunction against sale of escitalopram generics", by Sara Pelaz (Grau & Angulo), International Law Office, 3 May 2011
No comments:
Post a Comment